Marit S Bakken1,2, Jan Schjøtt3,4,5, Anders Engeland1,6, Lars B Engesaeter3,7, Sabine Ruths1,8. 1. Department of Global Public Health and Primary Care, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. 2. Kavli Research Centre for Geriatrics and Dementia, Haraldsplass Deaconess Hospital, Bergen, Norway. 3. Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway. 4. Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway. 5. Regional Medicines Information and Pharmacovigilance Centre, Haukeland University Hospital, Bergen, Norway. 6. Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. 7. Norwegian Arthroplasty Registry, Department of Orthopaedics and Department of Clinical Medicine, Haukeland University Hospital, Bergen, Norway. 8. Research Unit for General Practice, Uni Research Health, Bergen, Norway.
Abstract
OBJECTIVES: To examine associations between exposure to various subgroups of antipsychotic drugs and risk of hip fracture in older adults. DESIGN: Nationwide cohort study. SETTING: Norway, 2005-2010. PARTICIPANTS: Everyone living in Norway born before 1945 (N = 906,422). MEASUREMENTS: Information was obtained on all prescriptions of antipsychotic drugs dispensed from 2004 to 2010 (Norwegian Prescription Database) and data on all primary hip fractures from 2005 to 2010 (Norwegian Hip Fracture Registry). Incidence rates of hip fracture during person-time exposed and unexposed to antipsychotic drugs were compared by calculating the standardized incidence ratio (SIR). RESULTS: Thirty-nine thousand nine hundred thirty-eight (4.4%) participants experienced a primary hip fracture. Greater risk of hip fracture was associated with exposure to any antipsychotic (SIR = 2.1, 95% confidence interval (CI) = 1.9-2.1), first-generation antipsychotics (SIR = 2.0, 95% CI = 1.8-2.2), second-generation antipsychotics (SIR = 2.2, 95% CI = 1.9-2.4), prolactin-sparing antipsychotics (SIR = 2.4, 95% CI = 1.8-3.1) and prolactin-elevating antipsychotics (SIR = 2.0, 95% CI = 1.9-2.2). CONCLUSION: In people aged 60 and older in Norway, those who took an antipsychotic drug had twice the risk of sustaining a hip fracture during exposure than during nonexposure. Although confounding by indication, comorbidity, or other drugs used cannot be excluded, this association is relevant for clinical practice because hip fracture and antipsychotic drug use are prevalent in vulnerable older individuals. Clinical studies examining mechanisms or causality of the observed association between antipsychotic drug use and excess risk of hip fracture are needed.
OBJECTIVES: To examine associations between exposure to various subgroups of antipsychotic drugs and risk of hip fracture in older adults. DESIGN: Nationwide cohort study. SETTING: Norway, 2005-2010. PARTICIPANTS: Everyone living in Norway born before 1945 (N = 906,422). MEASUREMENTS: Information was obtained on all prescriptions of antipsychotic drugs dispensed from 2004 to 2010 (Norwegian Prescription Database) and data on all primary hip fractures from 2005 to 2010 (Norwegian Hip Fracture Registry). Incidence rates of hip fracture during person-time exposed and unexposed to antipsychotic drugs were compared by calculating the standardized incidence ratio (SIR). RESULTS: Thirty-nine thousand nine hundred thirty-eight (4.4%) participants experienced a primary hip fracture. Greater risk of hip fracture was associated with exposure to any antipsychotic (SIR = 2.1, 95% confidence interval (CI) = 1.9-2.1), first-generation antipsychotics (SIR = 2.0, 95% CI = 1.8-2.2), second-generation antipsychotics (SIR = 2.2, 95% CI = 1.9-2.4), prolactin-sparing antipsychotics (SIR = 2.4, 95% CI = 1.8-3.1) and prolactin-elevating antipsychotics (SIR = 2.0, 95% CI = 1.9-2.2). CONCLUSION: In people aged 60 and older in Norway, those who took an antipsychotic drug had twice the risk of sustaining a hip fracture during exposure than during nonexposure. Although confounding by indication, comorbidity, or other drugs used cannot be excluded, this association is relevant for clinical practice because hip fracture and antipsychotic drug use are prevalent in vulnerable older individuals. Clinical studies examining mechanisms or causality of the observed association between antipsychotic drug use and excess risk of hip fracture are needed.
Authors: Sebastian Voigt-Radloff; Claudia Bollig; Gabriel Torbahn; Michael Denkinger; Jürgen Bauer Journal: Z Gerontol Geriatr Date: 2020-02 Impact factor: 1.281
Authors: Eric A Lee; Jeffrey W Brettler; Michael H Kanter; Steven G Steinberg; Peter Khang; Christopher C Distasio; John Martin; Mark Dreskin; Nolan H Thompson; Timothy M Cotter; Kim Thai; Lyn Yasumura; Nancy E Gibbs Journal: Perm J Date: 2019-12-11
Authors: Shoshana J Herzig; Michael B Rothberg; Caitlyn R Moss; Geeda Maddaleni; Suzanne M Bertisch; Jenna Wong; Wenxiao Zhou; Long Ngo; Timothy S Anderson; Jerry H Gurwitz; Edward R Marcantonio Journal: Sleep Date: 2021-09-13 Impact factor: 6.313